BIOMAT Database Logo BIOMAT Database Logo

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. 1982

G Di Chiro, and R L DeLaPaz, and R A Brooks, and L Sokoloff, and P L Kornblith, and B H Smith, and N J Patronas, and C V Kufta, and R M Kessler, and G S Johnston, and R G Manning, and A P Wolf

Positron emission tomography was used to measure local cerebral glucose utilization by the 1-[18F]fluoro-2-deoxy-D-glucose technique in 23 patients with cerebral gliomas. All 10 high-grade (III and IV) astrocytomas demonstrated a region of high activity with a glucose consumption of 7.4 +/- 3.5 (SD) mg/100 gm per minute. The 13 low-grade (I and II) gliomas had a glucose metabolic rate of 4.0 +/- 1.8 mg/100 gm per minute, with no distinctly visible hot spot. Thus, we found a correlation between rate of glycolysis and malignancy in primary cerebral tumors. Cerebral cortical glucose utilization was often depressed in areas adjacent to or neurally connected to the tumor site, and there was focal irregular delta wave EEG activity in these areas.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D005260 Female Females
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Di Chiro, and R L DeLaPaz, and R A Brooks, and L Sokoloff, and P L Kornblith, and B H Smith, and N J Patronas, and C V Kufta, and R M Kessler, and G S Johnston, and R G Manning, and A P Wolf
Latrepirdine increases cerebral glucose utilization in aged mice as measured by [18F]-fluorodeoxyglucose positron emission tomography.
August 2011, Neuroscience,
G Di Chiro, and R L DeLaPaz, and R A Brooks, and L Sokoloff, and P L Kornblith, and B H Smith, and N J Patronas, and C V Kufta, and R M Kessler, and G S Johnston, and R G Manning, and A P Wolf
Thoracic [18F]fluorodeoxyglucose uptake measured by positron emission tomography/computed tomography in pulmonary hypertension.
June 2016, Medicine,
G Di Chiro, and R L DeLaPaz, and R A Brooks, and L Sokoloff, and P L Kornblith, and B H Smith, and N J Patronas, and C V Kufta, and R M Kessler, and G S Johnston, and R G Manning, and A P Wolf
Neurolymphomatosis detected by 18F-fluorodeoxyglucose-positron emission tomography.
July 2020, EJHaem,
G Di Chiro, and R L DeLaPaz, and R A Brooks, and L Sokoloff, and P L Kornblith, and B H Smith, and N J Patronas, and C V Kufta, and R M Kessler, and G S Johnston, and R G Manning, and A P Wolf
[18F]fluorodeoxyglucose uptake in neonatal acute lung injury measured by positron emission tomography.
June 1997, Pediatric research,
G Di Chiro, and R L DeLaPaz, and R A Brooks, and L Sokoloff, and P L Kornblith, and B H Smith, and N J Patronas, and C V Kufta, and R M Kessler, and G S Johnston, and R G Manning, and A P Wolf
Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
January 1991, Acta radiologica. Supplementum,
G Di Chiro, and R L DeLaPaz, and R A Brooks, and L Sokoloff, and P L Kornblith, and B H Smith, and N J Patronas, and C V Kufta, and R M Kessler, and G S Johnston, and R G Manning, and A P Wolf
Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by 18F-fluorodeoxyglucose positron emission tomography.
October 2020, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
G Di Chiro, and R L DeLaPaz, and R A Brooks, and L Sokoloff, and P L Kornblith, and B H Smith, and N J Patronas, and C V Kufta, and R M Kessler, and G S Johnston, and R G Manning, and A P Wolf
Gallbladder lymphoma detected by 18F-fluorodeoxyglucose positron emission tomography.
January 2020, World journal of nuclear medicine,
G Di Chiro, and R L DeLaPaz, and R A Brooks, and L Sokoloff, and P L Kornblith, and B H Smith, and N J Patronas, and C V Kufta, and R M Kessler, and G S Johnston, and R G Manning, and A P Wolf
Thoracic positron emission tomography: 18F-fluorodeoxyglucose and beyond.
November 2020, Journal of thoracic disease,
G Di Chiro, and R L DeLaPaz, and R A Brooks, and L Sokoloff, and P L Kornblith, and B H Smith, and N J Patronas, and C V Kufta, and R M Kessler, and G S Johnston, and R G Manning, and A P Wolf
[Basic principles of 18F-fluorodeoxyglucose positron emission tomography].
January 2002, Acta medica Austriaca,
G Di Chiro, and R L DeLaPaz, and R A Brooks, and L Sokoloff, and P L Kornblith, and B H Smith, and N J Patronas, and C V Kufta, and R M Kessler, and G S Johnston, and R G Manning, and A P Wolf
[In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
April 1986, No to shinkei = Brain and nerve,
Copied contents to your clipboard!